Proteins in cerebrospinal fluid and blood: Barriers, CSF flow rate and source-related dynamics

Restorative Neurology and Neuroscience

Volumn 21, Issue 3-4, 2003, Pages 79-96

  Reiber, Hansotto ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Blood brain barrier; Blood CSF barrier function; Blood derived proteins; Brain derived proteins; Cerebrospinal fluid; CSF flow; Protein dynamics; Theory

Indexed keywords

ALBUMIN; BRAIN PROTEIN; IMMUNOGLOBULIN; NEURON SPECIFIC ENOLASE;

BLOOD BRAIN BARRIER; BLOOD VESSEL WALL; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID FLOW; CONFERENCE PAPER; DIFFUSION; DYNAMICS; FLOW RATE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; VENOUS BLOOD;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CEREBROSPINAL FLUID PROTEINS; HUMANS; PROTEINS; SERUM ALBUMIN;

EID: 0142257913     PISSN: 09226028     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (36)

1. W.W. Tourtellotte, On cerebrospinal fluid immunoglobulin-G (IgG) quotients in multiple sclerosis and other diseases. A review and a new formula to estimate the amount of IgG synthesized per day by the central nervous system, J Neurol Sci 10 (1970), 279-304.
2. H. Link and G. Tibbling, Principles of albumin and IgG disorders. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis, Scan J Clin Lab Invest 37 (1977), 397-401.
3. H. Reiber, The discrimination between different blood-CSF barrier dysfunctions and inflammatory reactions of the CNS by a recent evaluation graph for the protein profile of CSF, J Neurol 224 (1980), 89-99.
4. K. Ganrot-Norlin, Relative concentrations of albumin and IgG in cerebrospinal fluid in health and in acute meningitis, Scand J Infect Dis 10 (1978), 57-60.
5. H. Reiber, Evaluation of blood-cerebrospinal fluid barrier dysfunctions in neurological diseases, in: The Blood-Brain Barrier in Health and Disease, A.J. Suckling, M.G. Rumsby and M.W.B. Bradbury, eds, Ellis Horwood, Chichester, 1986, pp. 147-157.
6. J.H.M. Souverijn, H.M.P. Serrée, R. Peet, S.W. Grenzebach and G.W. Bruyn, Intrathecal immunoglobulin synthesis. Comparison of various formulae with the "gold standard" of isoelectric focusing, J Neurol Sci 102 (1991), 11-16.
7. S. Öhman, J. Ernerudh, P. Forsberg, H. von Schenck and M. Vrethem, Improved formulae for the judgement of intrathecally produced IgA and IgM in the presence of blood-CSF barrier damage, Ann Clin Biochem 30 (1993), 454-462.
8. C.B. Laurell, On the origin of major CSF proteins, in: Advances in CSF Protein Research and Diagnosis, E.J. Thompson, ed., MTP Press Ltd, Lancaster, England, 1987, pp. 123-128.
9. H. Reiber and K. Felgenhauer, Protein transfer at the blood-CSF barrier and the quantitation of the humoral immune response within the central nervous system, Clin. Chim. Acta 163 (1987), 319-328.
10. H. Reiber, Flow rate of cerebrospinal fluid (CSF) - a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases, J Neurol Sci 122 (1994), 189-203.
11. H. Reiber and J.B. Peter, Cerebrospinal fluid analysis - disease-related data patterns and evaluation programs, J. Neurol. Sci. 184 (2001), 101-122.
12. H. Reiber, M. Otto, C. Trendelenburg and A. Wormek, Reporting cerebrospinal fluid data - knowledge base and interpretation software, Clin. Chem. Lab. Med. 39 (2001), 324-332.
13. M. Otto, J. Wiltfang, L. Cepek, M. Neumann, B. Mollenhauer, P. Steinacker, B. Ciesielcyk, W. Schulz-Schaeffer, H.A. Kretzschmar and S. Poser, Tau Protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease, Neurology 58 (2002), 192-198.
14. I. Zerr, M. Bodemer and S. Räcker et al., Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease, Lancet 345 (1995), 1609-1610.
15. H. Schaarschmidt, H. Prange and H. Reiber, Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases, Stroke 24 (1994), 558-565.
16. F. Hulstaert, K. Blennow and A. Ivanoiu et al., Improved discrimination of AD patients using β-amyloid (1-42) and tau levels in CSF, Neurology 52 (1999), 1555-1562.
17. P. Lewczuk, H. Reiber and H. Tumani, Intercellular adhesion molecule-1 in cerebrospinal fluid - the evaluation of blood-derived and brain-derived fractions in neurological diseases, J. Neuroimmunol. 87 (1998), 156-161.
18. B. Romner, T. Ingebrigtsen, P. Kongstad and S.E. Borgesen, Traumatic braindamage: serum S-100 protein measurements related to neuroradiological findings. J Neurotrauma 17 (2000), 641-647.
19. H. Reiber, Dynamic of brain proteins in cerebrospinal fluid, Clin Chim Acta 310 (2001), 173-186.
20. J.D. Huber, R.D. Egleton and T.P. Davis, Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier, Trends Neurosci. 24 (2001), 719-725.
21. L.L. Rubin and J.M. Staddon, The cell biology of the blood-brain barrier, Annu. Rev. Neurosci. 22 (1999), 11-28.
22. E.J. Thompson, (ed.), The CSF Proteins: A Biochemical Approach, Amsterdam: Elsevier, 1988.
23. R.M. Herndon and R.A. Brumback, The cerebrospinal fluid, Kluwer Acad Publishers, Boston, 1989.
24. H. Davson, Physiology of the ocular and cerebrospinal fluids, Churchill, London, 1956.
25. R.K. Parkkola, M.E.S. Komu, TM. Äärimaa, M.S. Alanen and C. Thomsen, Cerebrospinal fluid flow in children with normal and dilated ventricles studied by MR-imaging, Acta Radiol. 42 (2001), 33-38.
26. D. Greitz and J. Hannerz, A proposed model of cerebrospinal fluid circulation: observations with radionuclide cisternography, Am J. Neuroradiol. 17 (1996), 431-438.
27. C. Strik, U. Klose, M. Erb, H. Strik and W. Grodd, Intracranial oscillations of cerebrospinal fluid and blood flows: Analysis with magnetic resonance imaging, J. Mag. Res. Imaging 15 (2002), 251-258.
28. C. May, S.A. Kays, J.R. Attack, M.B. Schapiro, R.P. Friedland and S.I. Rapopport, Cerebrospinal fluid production is reduced in healthy aging, Neurology 40 (1990), 500-503.
29. H. Reiber, M. Ruff and M. Uhr, Ascorbate concentration in human cerebrospinal fluid (CSF) and serum. Intrathecal accumulation and CSF flow rate, Clin. Chim. Acta 217 (1993), 163-173.
30. P. Rieckmann and H.P. Hartung, Neuroimmunologie, in: Klinische Neurobiologie - Molekulare Pathogenese und Therapie von neurologischen Erkrankungen, T. Herdegen, T.-R. Tölle and M. Bähr, eds, Spektrum Akademischer Verlag, Heidelberg, 1997.
31. K. Felgenhauer, Protein size and cerebrospinal fluid composition, Klin Wschr 52 (1974), 1158-1164.
32. A.M. Turing, The chemical basis of morphogenesis Phil, Trans. R. Soc. B. 237 (1952), 37-72.
33. A. Grubb and H. Löfberg, Human gamma-trace. Structure, function and clinical use of concentration measurements, Scan. J. Clin. Lab. Invest. Suppl. 177 (1985), 7-13.
34. S. Seyfert and A. Faulstich, Is the blood-CSF barrier altered in disease? Acta Neurol Scand (2003), (in press).
35. S.I. Rapoport, Passage of proteins from blood to cerebrospinal fluid, in: Neurobiology of Cerebrospinal Fluid, (Vol. 2), J.H. Wood, ed., Plenum Press, New York, 1983, pp. 233-245.
36. C. Jacobi and H. Reiber, Clinical relevance of increased neuron-specific enolase concentration in cerebrospinal fluid, Clin. Chim. Acta 177 (1988), 49-54.